Literature DB >> 27614654

HIV, Aging, and Viral Coinfections: Taking the Long View.

Tamar H Taddei1,2, Vincent Lo Re3,4, Amy C Justice5,6,7,8.   

Abstract

Viral suppression of human immunodeficiency virus (HIV) with combination antiviral therapy (cART) has led to increasing longevity but has not enabled a complete return to health among aging HIV-infected individuals (HIV+). Viral coinfections are prevalent in the HIV+ host and are implicated in cancer, liver disease, and accelerated aging. We must move beyond a simplistic notion of HIV becoming a "chronic controllable illness" and develop an understanding of how viral suppression alters the natural history of HIV infection, especially at the intersection of HIV with other common viral coinfections in the context of an altered, aging immune system.

Entities:  

Keywords:  Aging; Cancer; Coinfection; HIV; HPV; Liver disease; Viral hepatitis

Mesh:

Substances:

Year:  2016        PMID: 27614654     DOI: 10.1007/s11904-016-0327-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  106 in total

1.  Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis.

Authors:  Vincent Lo Re; Mindy Schuster
Journal:  Ann Intern Med       Date:  2015-11-24       Impact factor: 25.391

2.  New approaches to molecular diagnosis.

Authors:  Bruce R Korf; Heidi L Rehm
Journal:  JAMA       Date:  2013-04-10       Impact factor: 56.272

3.  Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.

Authors:  José Vicente Fernández-Montero; Eugenia Vispo; Pablo Barreiro; Rocío Sierra-Enguita; Carmen de Mendoza; Pablo Labarga; Vincent Soriano
Journal:  Clin Infect Dis       Date:  2014-03-14       Impact factor: 9.079

4.  Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.

Authors:  Jeffrey M Collins; Kara Loren Raphael; Charles Terry; Emily J Cartwright; Anjana Pillai; Frank A Anania; Monica M Farley
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

5.  Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies.

Authors:  Jianmeng Chen; Jeffry Florian; Wendy Carter; Russell D Fleischer; Thomas S Hammerstrom; Pravin R Jadhav; Wen Zeng; Jeffrey Murray; Debra Birnkrant
Journal:  Gastroenterology       Date:  2013-03-05       Impact factor: 22.682

6.  Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.

Authors:  Mark S Sulkowski; Susanna Naggie; Jacob Lalezari; Walford Jeffrey Fessel; Karam Mounzer; Margaret Shuhart; Anne F Luetkemeyer; David Asmuth; Anuj Gaggar; Liyun Ni; Evguenia Svarovskaia; Diana M Brainard; William T Symonds; G Mani Subramanian; John G McHutchison; Maribel Rodriguez-Torres; Douglas Dieterich
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

Review 7.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

8.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs.

Authors:  Hilary A Robbins; Christina E Fennell; Maura Gillison; Weihong Xiao; Yingshi Guo; Alicia Wentz; Gregory D Kirk; Shruti H Mehta; Gypsyamber D'Souza
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

View more
  9 in total

1.  Among patients with unhealthy alcohol use, those with HIV are less likely than those without to receive evidence-based alcohol-related care: A national VA study.

Authors:  Emily C Williams; Gwen T Lapham; Susan M Shortreed; Anna D Rubinsky; Jennifer F Bobb; Kara M Bensley; Sheryl L Catz; Julie E Richards; Katharine A Bradley
Journal:  Drug Alcohol Depend       Date:  2017-03-06       Impact factor: 4.492

2.  Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.

Authors:  Sasisopin Kiertiburanakul; David Boettiger; Oon Tek Ng; Nguyen Van Kinh; Tuti Parwati Merati; Anchalee Avihingsanon; Wing-Wai Wong; Man Po Lee; Romanee Chaiwarith; Adeeba Kamarulzaman; Pacharee Kantipong; Fujie Zhang; Jun Yong Choi; Nagalingeswaran Kumarasamy; Rossana Ditangco; Do Duy Cuong; Shinichi Oka; Benedict Lim Heng Sim; Winai Ratanasuwan; Penh Sun Ly; Evy Yunihastuti; Sanjay Pujari; Jeremy L Ross; Matthew Law; Somnuek Sungkanuparph
Journal:  AIDS Res Ther       Date:  2017-05-05       Impact factor: 2.250

3.  Antiretroviral-Mediated Microglial Activation Involves Dysregulated Autophagy and Lysosomal Dysfunction.

Authors:  Ashutosh Tripathi; Annadurai Thangaraj; Ernest T Chivero; Palsamy Periyasamy; Shannon Callen; Maria E Burkovetskaya; Ming-Lei Guo; Shilpa Buch
Journal:  Cells       Date:  2019-09-28       Impact factor: 6.600

4.  Long Non-coding RNA GAS5 Regulates T Cell Functions via miR21-Mediated Signaling in People Living With HIV.

Authors:  Lam Ngoc Thao Nguyen; Lam Nhat Nguyen; Juan Zhao; Madison Schank; Xindi Dang; Dechao Cao; Sushant Khanal; Bal Krishna Chand Thakuri; Zeyuan Lu; Jinyu Zhang; Zhengke Li; Zheng D Morrison; Xiao Y Wu; Mohamed El Gazzar; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

5.  Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.

Authors:  Jinyu Zhang; Bal Krishna Chand Thakuri; Juan Zhao; Lam N Nguyen; Lam N T Nguyen; Dechao Cao; Xindi Dang; Sushant Khanal; Madison Schank; Zeyuan Lu; Xiao Y Wu; Zheng D Morrison; Mohamed El Gazzar; Zhengke Li; Yong Jiang; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

6.  HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.

Authors:  Brandy E Wade; Kristi M Porter; Sharilyn Almodovar; Justin M Smith; Robert A Lopez-Astacio; Kaiser Bijli; Bum-Yong Kang; Sushma K Cribbs; David M Guidot; Deborah Molehin; Bryan K McNair; Laura Pumarejo-Gomez; Jaritza Perez Hernandez; Ethan A Salazar; Edgar G Martinez; Laurence Huang; Cari F Kessing; Edu B Suarez-Martinez; Kevin Pruitt; Priscilla Y Hsue; William R Tyor; Sonia C Flores; Roy L Sutliff
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

7.  ATM Deficiency Accelerates DNA Damage, Telomere Erosion, and Premature T Cell Aging in HIV-Infected Individuals on Antiretroviral Therapy.

Authors:  Juan Zhao; Lam Ngoc Thao Nguyen; Lam Nhat Nguyen; Xindi Dang; Dechao Cao; Sushant Khanal; Madison Schank; Bal Krishna Chand Thakuri; Stella C Ogbu; Zheng D Morrison; Xiao Y Wu; Zhengke Li; Yue Zou; Mohamed El Gazzar; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

8.  1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity.

Authors:  Jenny Desantis; Serena Massari; Angela Corona; Andrea Astolfi; Stefano Sabatini; Giuseppe Manfroni; Deborah Palazzotti; Violetta Cecchetti; Christophe Pannecouque; Enzo Tramontano; Oriana Tabarrini
Journal:  Molecules       Date:  2020-03-05       Impact factor: 4.411

9.  Use and Perceptions of Opioids Versus Marijuana among Cancer Survivors.

Authors:  Jessica M Potts; Betelihem Getachew; Milkie Vu; Eric Nehl; Katherine A Yeager; Corinne R Leach; Carla J Berg
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.